Cognitive · CNTF Mimetic

P21

P21 is a peptide derivative of ciliary neurotrophic factor (CNTF) studied for memory enhancement, neuroprotection, and reversal of cognitive decline.

Category: Cognitive Enhancement Last updated 2026-05-11
P21 at a glance

P21 is a peptide derivative of ciliary neurotrophic factor (CNTF) studied for memory enhancement, neuroprotection, and reversal of cognitive decline. Mechanism: CNTF-mimetic peptide. Typical route: Subcutaneous, oral, intranasal. FDA status: Not FDA-approved. Limited compounding-pharmacy availability; most current sources are research-chemical suppliers, which have variable quality controls.

Drug classCNTF-mimetic peptide
Half-life~2 hours
RouteSubcutaneous, oral, intranasal
Common dosing0.5-1 mg/day
FDA statusNot approved
Available throughResearch suppliers (mostly)

Mechanism of action

P21 mimics the neurogenic effects of CNTF by stimulating proliferation and survival of neural progenitor cells in the hippocampus and supporting adult neurogenesis. Preclinical models show enhanced learning and memory.

Dosing reference

Subcutaneous: 0.5-1 mg daily. Cycled 5 days on / 2 days off for 4-8 weeks. Oral and intranasal formulations are also used in some protocols.

Dosing information is provided for educational reference and is not medical advice. Patients should not initiate or modify any peptide regimen without consulting a licensed clinician. See our medical disclaimer.

FDA status & regulatory framework

Not FDA-approved. Limited compounding-pharmacy availability; most current sources are research-chemical suppliers, which have variable quality controls.

U.S. telehealth providers that work with P21

#1 of 3
71/100v3.0 six-pillar rubric

Starting at $125/mo. PeterMD is one of the providers covered in our editorial directory that dispenses or coordinates P21.

Read review →
#2 of 3
85/100v3.0 six-pillar rubric

Starting at $180/mo. Marek Health is one of the providers covered in our editorial directory that dispenses or coordinates P21.

Read review →
#3 of 3
88/100v3.0 six-pillar rubric

Starting at $160/mo. Defy Medical is one of the providers covered in our editorial directory that dispenses or coordinates P21.

Read review →

Related cognitive enhancement peptides

Browse the full Cognitive Enhancement category →

Frequently asked questions about P21

What is P21 used for?

P21 is used in cognitive-enhancement protocols, particularly by patients interested in adult neurogenesis support, post-concussion recovery, and age-related cognitive decline.

How does P21 differ from Cerebrolysin?

P21 is a single defined peptide acting through CNTF receptor pathways. Cerebrolysin is a cocktail of brain-derived neuropeptides. Cerebrolysin has substantially more clinical-trial evidence; P21 is more of a research-stage compound.

Lead Medical Researcher
Dr. Sam Saberian
Doctor of Pharmacy; leads protocol research, peptide pharmacology, and provider evaluation.
Medical Reviewer
Alen A. Schwartz, MD
Board-certified physician; reviews clinical accuracy of every published page.
Edited by
Julliana Edwards
Editorial standards, factual accuracy, and corrections workflow.